학술논문
Prevalence, incidence and persistence of etanercept and adalimumab in Norway 2005-2009.
Document Type
Article
Source
Pharmacoepidemiology & Drug Safety; May2011, Vol. 20 Issue 5, p457-463, 7p, 1 Diagram, 2 Charts, 3 Graphs
Subject
Language
ISSN
10538569
Abstract
The article features the examination which was conducted to etanercept and adalimumab in terms of their prevalence, incidence and persistence of use in Norway during 2005-2009. The data from Norwegian Prescription Database (NorPD) for persons who were administered with etanercept and adalimumab from 2005 to 2009 were collected. It has been found out that there is an increase in the prevalence and incidence of using etanercept and adalimumab from 2005 to 2009 with the highest prevalence for both men and women aged 50-69.